معرفی
Kathryn Gilstad-Hayden is a Biostatistician at the Yale School of Medicine, Yale University. Her work focuses on statistical methodologies applied to public health challenges, particularly substance misuse interventions in reproductive and maternal health contexts. She specializes in designing and analyzing clinical trials evaluating brief behavioral interventions for cigarette, alcohol, and illicit drug use among women in reproductive healthcare settings.
Key research areas include developing evidence-based strategies to address substance use during pregnancy/postpartum, leveraging both electronic and clinician-delivered approaches. Her studies often involve randomized controlled trials to assess intervention efficacy, with recent contributions to understanding postpartum smoking cessation treatments and maternal substance use screening protocols.
Her academic contributions are centered at the intersection of biostatistics and clinical public health, emphasizing translational research to improve patient outcomes. Collaborations likely involve multidisciplinary teams across obstetrics, addiction medicine, and data science.
